StockData

AVAI Bio, Inc. (AVAI) stock

AVAIOTCServices-Computer Processing & Data PreparationFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.11−0.00 (-1.75%)

Close on Oct 19, 2026Market cap $17.24MP/E –Yield –

AVAI Bio operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

AVAI Bio's operating income for the twelve months ending Jun 30, 2026 was -$1.81M. For fiscal 2026 it was -$1.75M. The highest annual figure on record is $302.29K in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$1.75M–
FY2025Mar 31, 2025-$1.14M–
FY2024Mar 31, 2024-$2.13M–
FY2023Mar 31, 2023-$348.93K-375.8%
FY2022Mar 31, 2022$126.52K-58.1%
FY2021Mar 31, 2021$302.29K+334.4%
FY2020Mar 31, 2020$69.59K–
FY2019Mar 31, 2019-$78.23K–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026-$552.04K-213.2%
Q4 FY2026CQ1 2026Mar 31, 2026-$255.18K–
Q3 FY2026CQ4 2025Dec 31, 2025-$553.73K-222.4%
Q2 FY2026CQ3 2025Sep 30, 2025-$453.02K-172.7%
Q1 FY2026CQ2 2025Jun 30, 2025$487.59K–
Q4 FY2025CQ1 2025Mar 31, 2025-$2.75M–
Q3 FY2025CQ4 2024Dec 31, 2024$452.30K-55.4%
Q2 FY2025CQ3 2024Sep 30, 2024$623.05K+55.9%
Q1 FY2025CQ2 2024Jun 30, 2024-$528.84K-228.5%
Q4 FY2024CQ1 2024Mar 31, 2024-$3.95M–
Q3 FY2024CQ4 2023Dec 31, 2023$1.01M+817.8%
Q2 FY2024CQ3 2023Sep 30, 2023$399.62K+377.1%
Q1 FY2024CQ2 2023Jun 30, 2023$411.52K+1282.7%
Q4 FY2023CQ1 2023Mar 31, 2023-$572.93K-8058.4%
Q3 FY2023CQ4 2022Dec 31, 2022$110.47K-68.4%
Q2 FY2023CQ3 2022Sep 30, 2022$83.76K-49.6%
Q1 FY2023CQ2 2022Jun 30, 2022$29.76K–
Q4 FY2022CQ1 2022Mar 31, 2022$7.20K–
Q3 FY2022CQ4 2021Dec 31, 2021$349.33K-16.3%
Q2 FY2022CQ3 2021Sep 30, 2021$166.32K–
Q1 FY2022CQ2 2021Jun 30, 2021-$396.33K-914.1%
Q4 FY2021CQ1 2021Mar 31, 2021-$15.73K-110.3%
Q3 FY2021CQ4 2020Dec 31, 2020$417.16K–
Q2 FY2021CQ3 2020Sep 30, 2020-$50.46K–
Q1 FY2021CQ2 2020Jun 30, 2020$48.68K–
Q4 FY2020CQ1 2020Mar 31, 2020$152.64K–
Q4 FY2019CQ1 2019Mar 31, 2019-$26.70K–

More AVAI Bio figures

See a number that looks wrong?